Toll‑like receptor 4 plays a tumor‑suppressive role in cutaneous squamous cell carcinoma

  • Authors:
    • Erina Mikami
    • Mitsuhiro Kudo
    • Ryuji Ohashi
    • Kiyoko Kawahara
    • Yoko Kawamoto
    • Kiyoshi Teduka
    • Takenori Fujii
    • Taeko Kitamura
    • Shoko Kure
    • Kousuke Ishino
    • Takashi Sakatani
    • Ryuichi Wada
    • Hidehisa Saeki
    • Zenya Naito
  • View Affiliations

  • Published online on: April 17, 2019     https://doi.org/10.3892/ijo.2019.4790
  • Pages: 2179-2188
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Toll‑like receptor 4 (TLR4), a key regulator of the innate immune system, is expressed not only in immune cells, but also in a number of cancer cells. A biological role for TLR4 in cutaneous squamous cell carcinoma (SCC), however, is unclear. In this study, we first examined TLR4 expression and localization in cases of SCC, actinic keratosis (AK) and Bowen's disease (BD) by immunohistochemistry. TLR4 expression was significantly higher in the SCC than in the AK or BD tissues. We then determined the TLR4 expression level in vivo, in 3 histological subtypes of SCC. TLR4 expression in poorly differentiated SCC was significantly lower compared with that of the moderately and well‑differentiated type. In addition, the CD44 immunoreactivity tended to be high in the cell membrane of poorly differentiated SCC. Of note, poorly differentiated SCC is a risk factor of unfavorable outcomes in affected patients. We then assessed the biological role of TLR4 in HSC‑1 and HSC‑5 SCC cells and HaCaT human keratinocytes. TLR4 knockdown by transfection with siRNA accelerated HSC‑1 and HaCaT cell migration and invasion compared to the control siRNA‑transfected cells. TLR4 knockdown resulted in an increased CD44 expression and in an enhanced filopodia protrusion formation, particularly in HSC‑1. On the whole, these results suggest that a reduced TLR4 expression enhances the malignant features in SCC cases and cultured SCC cell lines. TLR4 may thus play an anti‑tumor role in cutaneous SCC.
View Figures
View References

Related Articles

Journal Cover

June 2019
Volume 54 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Mikami, E., Kudo, M., Ohashi, R., Kawahara, K., Kawamoto, Y., Teduka, K. ... Naito, Z. (2019). Toll‑like receptor 4 plays a tumor‑suppressive role in cutaneous squamous cell carcinoma. International Journal of Oncology, 54, 2179-2188. https://doi.org/10.3892/ijo.2019.4790
MLA
Mikami, E., Kudo, M., Ohashi, R., Kawahara, K., Kawamoto, Y., Teduka, K., Fujii, T., Kitamura, T., Kure, S., Ishino, K., Sakatani, T., Wada, R., Saeki, H., Naito, Z."Toll‑like receptor 4 plays a tumor‑suppressive role in cutaneous squamous cell carcinoma". International Journal of Oncology 54.6 (2019): 2179-2188.
Chicago
Mikami, E., Kudo, M., Ohashi, R., Kawahara, K., Kawamoto, Y., Teduka, K., Fujii, T., Kitamura, T., Kure, S., Ishino, K., Sakatani, T., Wada, R., Saeki, H., Naito, Z."Toll‑like receptor 4 plays a tumor‑suppressive role in cutaneous squamous cell carcinoma". International Journal of Oncology 54, no. 6 (2019): 2179-2188. https://doi.org/10.3892/ijo.2019.4790